Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Accessible Bio Companies Back Up the Importance of “Criminal” DIY Kits for the Future of Science Education
  • USA - English


News provided by

Biorealize Inc

Feb 09, 2017, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Anyone who is interested in exploring the world of the living should be able to pursue it, whether it is through DIY Biology, Biohacking, or PhDs in Life Sciences. This diversity is necessary.
Anyone who is interested in exploring the world of the living should be able to pursue it, whether it is through DIY Biology, Biohacking, or PhDs in Life Sciences. This diversity is necessary.

Philadelphia, PA (PRWEB) February 09, 2017 -- A response by Amino Labs and Biorealize, collectively, “Accessible Bio” companies.

For the German translation, please visit here.

Everyone should have the opportunity to unearth their passion for solving humanity’s grand challenges through biology, regardless of their access to university labs.

Post this

On Friday February 3rd, 2017, Make Magazine (Germany) published "Biohacking: Federal Office warns against Do-It-Yourself kits", pointing to the German federal government's declaration on GM projects. This declaration, published by the German government on January 25th, 2017, as “"Genetic engineering with biology kits: simple, but potentially criminal", outlines the current legislation for the handling of “DIY genetic engineering kits” bought from abroad (North America).

Who can do genetic engineering experiments, and where can they do them? These are the types of questions that very frequently arise in European countries as the accessible science movement gains momentum worldwide. Unfortunately, each European country has slightly different rules, making it difficult to get a straight answer. Since the DIYbio and Maker movements are growing rapidly around the world and Making with Biology outside of universities and corporations is now an exciting and feasible exercise no longer relegated to the realm of science fiction, it is important for governments to clearly delineate the current laws and regulations. In fact, looking at the German DIYbio Google Group, the legal uncertainties surrounding DIYbio in the home are brought evident. The German government along with Make: have done Europe a service in clarifying the rules in Germany.

Initially when reading the Make: article using Google Translate (as many native English speakers would do), it comes across as polarizing, and even suggests that the products are potentially “criminal kits.” After a careful read, one would realize that the intention is not to crackdown on biohacking or limiting access to hands-on biology education but that it is rather a timely reminder of the containment level and environment required in Germany to complete genetic engineering tasks. For this, we see the German government's move to clarify the current rules as a positive undertaking. Furthermore, the Make: article closes on a constructive note with a link to information about how non-scientists in Germany can learn about biotechnology and genetic engineering.

The “Accessible Bio” companies recommend that all European countries follow Germany’s lead and clearly and concisely communicate GM regulations to DIYbio and makers in their countries, as well as recommend appropriate locations where this type of exploration can be done if they are unable to complete the Risk Group 1 experiments at home. For example, in the United Kingdom you can find accredited DIYbio labs such as MadLab and London Biohackspace. In the Netherlands, the Waag Society, La Paillasse in France, and the OpenBiolab in Austria.

Efforts are also being made by EKoli, a European “Maker” initiative that aims to standardize and make learning and hands-on genetic engineering possible for Belgium schools. “We’re pursuing and working with government to establish a scalable model for setting up appropriate containment levels in an ad hoc basis in schools, so that this important [genetic engineering] content can be effectively taught.”, says co-founder Deepak Mehta.

“We are North American companies building products for North American customers, under the North American regulatory framework. At the moment, it is more complicated for those in European countries who wish to learn about genetic engineering hands-on as the rules are unclear”, says Justin Pahara, Fellow of the Johns’ Hopkins Emerging Leaders in Biosecurity Initiative (ELBI) and former Biosafety Committee member of the Department of Chemical Engineering and Biotechnology at the University of Cambridge. “Safety is one of our greatest considerations, and we encourage everyone who purchases our product(s) to comply with their local containment laws and follow the safety and disposal instructions.”

In North America, these DIY, Education, and Design kits do not require regulated containment as they are considered non-harmful to humans or the environment. The regulations for containment in North America begin with potentially hazardous agents and pathogens.

“We design our kits and technologies in response to information inequality” says Orkan Telhan, co-founder of Biorealize and faculty of Emerging Design Practices at University of Pennsylvania. "Not everyone has access to the same resources and infrastructure to start learning biology. And anyone who is interested in exploring the world of the living should be able to pursue it, whether it is through DIY Biology, Biohacking, or PhDs in Life Sciences. This diversity is necessary. These educational kits are stepping stones that will turn young curious minds into a growing community of professionals who can design the next generation applications of biology.”

“Through our research, we found that once a person reaches the age of 16, they’ve often already decided on a career path based on the opportunities they have had access to”, says Julie Legault, CEO of Amino Labs. “The world needs innovation that leads to more abundant and cheaper medicine - more nutritious and non-animal-based sustainable food options - more eco-friendly and sustainable manufacturing methods — all of which will lead to economic growth. Genetic engineering is a key tool for achieving these goals, and, as a complex topic, is best explored hands-on. Everyone should have the opportunity to unearth their passion for solving humanity’s grand challenges through biology, regardless of their access to university labs.”

We see this response as an opportunity to jointly express our commitment to make biology accessible to anyone who would be willing to use it responsibly.

We invite the all policy-makers and enforcers of GM laws to consider the following:

The mission of “Accessible Bio” companies is mainly to address information inequality. We intend to support biotech education to make it more accessible to those who do not have the resources.

We invite all stakeholders to be in dialogue with each other to address the regulatory concerns together. There is no need to contemplate, pass and/or enforce regulation due to fear and unverified opinions.

We are always ready to hear new perspectives from everyone who would like to learn genetic engineering with our kits and technologies. We are ready to improve our products to support your interests.

Orkan Telhan, Biorealize Inc, http://biorealize.com, +1 7164006221, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.